Join
Live feed
·
PRReleasevia Quantisnow
Clene Inc. logo

Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8®

ByQuantisnow·Wall Street's wire, on your screen.
CLNN· Clene Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLNN (Clene Inc.) and more on Quantisnow.